Program Director:
Dima M. Qato, PharmD, MPH, PhD
qato@usc.edu
Director, USC Program on Medicines and Public Health, USC School of Pharmacy
Senior Fellow, USC Schaeffer Center
Hygeia Centennial Chair and Associate Professor, USC School of Pharmacy
Profile
Dr. Qato serves as the Hygeia Centennial Chair and Associate Professor (with tenure) in the Titus Family Department of Clinical Pharmacy. In her newly appointed role as Director of the Program on Medicines and Public Health, she will develop and lead interdisciplinary research efforts focusing on drug utilization, access to medicines, and pharmaceutical policy both in the U.S. and globally to better understand why medications are used, or not used, and how they can and should be used in the population to promote equity, longevity and good health. Dr. Qato’s goal is to promote public accountability to better ensure access to, and safe use of, medications at the national, state and local levels.
Program Members:
Katharine Ozenberger, MS, PhD(c)
ozenberg@usc.edu
Senior Research Associate
Katharine specializes in epidemiology and pharmacoepidemiology. Her research focuses on medication utilization and safety, using longitudinal data from population-based cohorts, prescription dispensing, and all-payer health claims. Katharine’s interdisciplinary approach leverages prior experience in public health outreach and program evaluation.
Elkanah Linder
Research Affiliate
Elkanah received her PharmD in 2021 and thereafter went to Sweden with a Fulbright Scholarship. As part of the pharmacoepidemiology research group at Uppsala University in Uppsala, Sweden, her Fulbright research focused on stakeholders’ perspectives and use of web-based knowledge support systems that provide environmental information on pharmaceuticals. Her research interests include the intersection of the climate change and the environment with healthcare and healthcare education. She currently works as a community pharmacist in Vermont.
Hyung-Jin Kim
Research Affiliate
Hyung-Jin Kim received his Ph.D. in Economics in the summer of 2024. He is interested in exploring questions at the intersection of Industrial Organization, Health Economics, and Machine Learning. His recent research focuses on market consolidation in the healthcare sector and related antitrust policies.
Affiliated Faculty:
Jenny S. Guadamuz, MPH, PhD
Assistant Professor
Health Policy & Management
UC Berkeley School of Public Health
Profile
Gregory Calip, PhD
Adjunct Associate Professor
Dr. Gregory Calip is an experienced pharmacoepidemiologist and biostatistician specializing in hematology, oncology, and cancer health equity research. He is recognized as a scientific authority in quantitative research methods and real-world evidence for his demonstrated expertise in cancer epidemiology, biostatistics and drug safety. He has conducted extensive research utilizing diverse datasets including population-based registries, electronic health records, administrative claims data, and clinical trials with over 15 years of experience in academia, health technology and biopharmaceutical industries.